Matthew Galeotti, the Head of the Criminal Division at the Department of Justice ("DOJ") issued a new white collar enforcement ...

Ozempic and Wegovy would no longer be covered by the state’s health insurance for low-income people under the governor’s ...

Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.

Kayla Girgen, RD, is a licensed dietitian who specializes in weight management and weight loss for patients after bariatric surgery. Water is the most abundant component in the body and is ...

Another win for the jab. GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced dementia risk to addiction treatment.

“We have learned over the past 20-odd years that in order to overcome plateau phenomenon in obesity, if you can add mechanisms that are completely different together, you can often get additional ...

Weight loss injections may have an anti-cancer effect "beyond weight loss", a new study suggests. Obesity is linked to 13 different cancers. Scientists have long known that losing weight can slash ...

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants who took Zepbound lost more weight than those who took Wegovy.

MALAGA, Spain—Patients with obesity treated with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy; Novo Nordisk) can achieve weight loss in the real world similar to what has ...

Weight-loss injections could cut the risk of cancer by almost half, research suggests. Researchers analysed the health records of more than 6,000 obese patients with Type 2 diabetes, half of whom ...

Please provide your email address to receive an email when new articles are posted on . Adults receiving tirzepatide lost more weight and had a greater decline in waist circumference than those ...